Quick Answer
Centessa Pharmaceuticals plc reported Shares Outstanding of 149.23 million shares for fiscal year 2025.
Centessa Pharmaceuticals plc Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 149.23M | +12.5% |
| 2024 | 132.63M | +34.3% |
| 2023 | 98.77M | +4.1% |
| 2022 | 94.84M | +5.4% |
| 2021 | 89.99M | — |
| 2020 | 0 | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 134.42M | +2.1% | +0.4% |
| June 30, 2025 | 133.91M | +18.3% | +0.3% |
| March 31, 2025 | 133.55M | +32.9% | +0.7% |
| December 31, 2024 | 132.63M | +34.3% | +0.7% |
| September 30, 2024 | 131.66M | +34.9% | +16.3% |
| June 30, 2024 | 113.18M | +18.8% | +12.6% |
| March 31, 2024 | 100.48M | +5.7% | +1.7% |
| December 31, 2023 | 98.77M | +4.1% | +1.2% |
- Centessa Pharmaceuticals plc showed an increase of +12.5% in Shares Outstanding compared to the prior fiscal year.
- The most recent figure is from Centessa Pharmaceuticals plc’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: